| Literature DB >> 29458794 |
Giorgio Bogani1, Umberto Leone Roberti Maggiore2, Mauro Signorelli2, Fabio Martinelli2, Antonino Ditto2, Ilaria Sabatucci2, Lavinia Mosca2, Domenica Lorusso2, Francesco Raspagliesi2.
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.Entities:
Keywords: Cervical cancer; HPV; Therapeutic vaccine; Vaccine
Mesh：
Substances：
Year: 2017 PMID： 29458794 DOI： 10.1016/j.critrevonc.2017.12.017
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312